A2 Biotherapeutics, Inc., a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to address the high unmet needs in cancer, announced the appointment...
VRG50635 is one of the first clinical-stage drugs discovered and developed entirely using an AI-powered platform
Verge Genomics, a leading clinical-stage biotechnology company, and Ferrer,...
Profluent, an AI-first protein design company, announced the close of additional funding to bring the total raised to $44M. The $35M financing was led...
Acquisition of MotionHall reinforces strategy to lead market-specific solutions, including workflows and expert services fuelled by industry vertical AI
Clarivate Plc a leading global provider of...
Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, announced excellent results across multiple clinical studies conducted with the University of Pittsburgh Medical Center...
Significant throughput of LSA to advance IPA’s diversity- and data-driven drug development and to enrich LENSai™.
IPA, an artificial intelligence-driven biotherapeutic research and technology company,...
BenevolentAI, a leader in applying advanced AI to accelerate biopharma drug discovery, announces that the current Chief Technology Officer (CTO), Dr. Daniel Neil, is...